loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 19959 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (1)

filter

01 NOVO NORDISK INC (1)

filter

01 INJECTABLE;INJECTION (1)

filter

01 100 UNITS/ML (1)

filter

01 USA (1)

URL Supplier Web Content
INJECTABLE;INJECTION
100 UNITS/ML
NOVOLIN N
USA
19959
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 19959

Looking for CTD TGA MCC DOSSIER APPLICATION 19959 1

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN SUSP ISOPHANE RECOMBINANT HUMAN, with a corresponding application number 19959 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOLIN N INJECTABLE;INJECTION, medication with 100 UNITS/ML of INSULIN SUSP ISOPHANE RECOMBINANT HUMAN.

Post Enquiry
POST ENQUIRY